Dec 21 (Reuters) - SENSORION SA ALSEN.PA :
* SENSORION ANNOUNCES PUBLICATION OF SENS-401 DATA IN
OTOLOGY &
NEUROLOGY JOURNAL
* RESULTS SHOWED THAT TWICE DAILY, LOWER DOSES OF SENS-401
FOR 28
DAYS WAS OPTIMAL DOSING REGIMEN FOR HEARING PROTECTION USING ALL
OUTCOME MEASURES
* TREATMENT REGIMEN ABLE TO DELIVER OTOPROTECTION AND
HEARING
RECOVERY WHEN ADMINISTRATION WAS DELAYED BY 96 HOURS AFTER
ACOUSTIC TRAUMA
Source text for Eikon: ID:nBw1rGMhZa
Further company coverage: ALSEN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))